7. Patient-derived scaffolds as a drug-testing platform for endocrine therapies2021-09-132021-09-13http://iscaffpharma.com/wp-content/uploads/2021/09/iscaff-logo-webb.pngIscaffpharmahttps://usercontent.one/wp/iscaffpharma.com/wp-content/uploads/2021/01/drug-fingerprint-2.jpg200px200px
